CellCentric
CellCentric is a clinical-stage biotech company focusing on the inhibition of p300/CBP to treat specific cancers, particularly solid tumors. The programme also has potential clinical utility in non-small cell lung, breast, and colon cancer. The company's oral drug, Inobrodib, is currently in Phase I/II clinical trials and aims to address cancers such as multiple myeloma. The company is committed to science-driven solutions for cancer, with a patient-focused approach to novel therapies.
Domain
cellcentric.com
Country
United KingdomIndustry
BiotechnologyEmployees
11-50
Last Funding
$120.0M
Founded
2002
Tech Stack (20 technologies)
Frequently Asked Questions
What technologies does CellCentric use?+
CellCentric uses 20 technologies including Elementor, Google Analytics, Google Tag Manager.
What industry is CellCentric in?+
CellCentric operates in the Biotechnology industry.
Where is CellCentric based?+
CellCentric is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026